Health Innovations Pharmacy, Inc.
FDA inspection history in Southern Pines, North Carolina, 2015 to 2016
- 1
- Close-out
- 1
- Form 483
Every document, by year
- Close-out
- Form 483
2015: one Form 483; 2016: one close-out letter.
The story so far
Built from the dates and citations on the documents themselves.
- 2015–16One Form 483 and one close-out letter, at Southern Pines, North Carolina.
Cited most
Across all Health Innovations Pharmacy observations on file
- 21 CFR 211.42(b)Design and construction features3
- 21 CFR 211.165(a)Testing and release for distribution2
- 21 CFR 211.111Time limitations on production1
- 21 CFR 211.113(b)Control of microbiological contamination1
- 21 CFR 211.166(a)Stability testing1
The complete Health Innovations Pharmacy file.
All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Southern Pines, North Carolina
One close-out letter and one Form 483 · 2015 to 2016 · 10 observations
Latest: Close-out, Jul 8, 2016 →
Documents
2 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2016-07-08 | Close-out Close-out letter | Southern Pines, North Carolina | — | $99 |
| 2015-02-27 | 483 Form 483 | Southern Pines, North Carolina | 10 | $99 |
Investigators on these documents
FEI number 3011364861 · most recent document Jul 8, 2016
About Health Innovations Pharmacy, Inc.
How many FDA Form 483s has Health Innovations Pharmacy, Inc. received?
FDA Intel has 1 Form 483 on file for Health Innovations Pharmacy, Inc.; the most recent is dated Feb 27, 2015.
When was Health Innovations Pharmacy, Inc. last inspected by FDA?
The most recent FDA inspection document on file for Health Innovations Pharmacy, Inc. is a Form 483 dated Feb 27, 2015, for the site in Southern Pines, North Carolina.
What did FDA cite at Health Innovations Pharmacy, Inc.?
The regulations cited most in the observations on file for Health Innovations Pharmacy, Inc. are 21 CFR 211.42(b) (Design and construction features), 3 times; 21 CFR 211.165(a) (Testing and release for distribution), 2 times; 21 CFR 211.111 (Time limitations on production), 1 time.